These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 12716529)
41. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia. Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521 [TBL] [Abstract][Full Text] [Related]
42. Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules. Wilson JN; Nokes DJ; Medley GF; Shouval D Vaccine; 2007 May; 25(18):3705-12. PubMed ID: 17306427 [TBL] [Abstract][Full Text] [Related]
43. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. de la Hoz F; Perez L; de Neira M; Hall AJ Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535 [TBL] [Abstract][Full Text] [Related]
44. [Hepatitis B immunoprophylaxis; vaccination of newborn infants]. Mazel JA; Schalm SW; Ypma TD Ned Tijdschr Geneeskd; 1984 Aug; 128(34):1620-2. PubMed ID: 6483034 [No Abstract] [Full Text] [Related]
45. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century. Yap SF Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102 [TBL] [Abstract][Full Text] [Related]
46. Vaccines for neonatal viral infections: hepatitis B vaccine. Cutts FT; Hall AJ Expert Rev Vaccines; 2004 Aug; 3(4):349-52. PubMed ID: 15270632 [TBL] [Abstract][Full Text] [Related]
47. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812 [TBL] [Abstract][Full Text] [Related]
48. [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou]. Lin CS; Zhu JY; Mai L; Lee WH; Gao ZL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):114-6. PubMed ID: 17653308 [TBL] [Abstract][Full Text] [Related]
49. Hepatitis B vaccine set for introduction into national immunization programs. Infect Control Hosp Epidemiol; 1992 Jun; 13(6):372. PubMed ID: 1535642 [No Abstract] [Full Text] [Related]
50. [A study on immune efficacy in children immunized by hepatitis B vaccine in disease surveillance points of Fujian]. Li L; Zhou Y; Zhao L; Xia S; Wang Z Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):372-4. PubMed ID: 15617252 [TBL] [Abstract][Full Text] [Related]
51. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection]. Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927 [TBL] [Abstract][Full Text] [Related]
52. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445 [TBL] [Abstract][Full Text] [Related]
53. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program. Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303 [TBL] [Abstract][Full Text] [Related]
54. Hepatitis B vaccination. Fagan EA; Williams R Br J Clin Pract; 1987 Jan; 41(1):569-76. PubMed ID: 2959306 [No Abstract] [Full Text] [Related]
55. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China. Liu SL; Dong Y; Zhang L; Li MW; Wo JE; Lu LW; Chen ZJ; Wang YZ; Ruan B Arch Virol; 2009; 154(3):437-43. PubMed ID: 19212700 [TBL] [Abstract][Full Text] [Related]
56. [Outcomes of Polish hepatitis B vaccination program in comparison with European Union]. Magdzik W Przegl Epidemiol; 2003; 57 Suppl 1():51-62. PubMed ID: 12921001 [No Abstract] [Full Text] [Related]
57. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. Suckling RM; Taegtmeyer M; Nguku PM; Al-Abri SS; Kibaru J; Chakaya JM; Tukei PM; Gilks CF J Hosp Infect; 2006 Nov; 64(3):271-7. PubMed ID: 16926061 [TBL] [Abstract][Full Text] [Related]
58. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613 [TBL] [Abstract][Full Text] [Related]
59. Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical HBV vaccination. Tarhan MO; Aker AI; Sipahi OR; Kardes G; Biberoglu K Med Sci Monit; 2006 Nov; 12(11):CR467-70. PubMed ID: 17072271 [TBL] [Abstract][Full Text] [Related]
60. [The assessment of efficacy of hepatitis B prophylaxis in children with acute lymphoblastic leukemia]. Moryl-Bujakowska A; Czogała M; Czogała W; Balwierz W Przegl Lek; 2004; 61 Suppl 2():85-8. PubMed ID: 15686054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]